The DCT Promise: Delivering Diverse Patient Populations
Decentralized clinical trials (DCTs) hold promise to reduce patient and sponsor burden and increase accrual and retention of a more diverse trial population, a key goal for oncology trials. This session provides an update on telemedicine and other aspects of DCTs that are being implemented at oncology sites.
Facilitator
Lindsey Morales, Associate Director, Clinical Site Partners, Gilead
Panelists
Kelly McKee, VP, Decentralized Trials, Medidata
Emilia Mondragón, MSN, RN, Clinical Research Lead, MRN
Patricia Salter, Senior Director, Head of Global Decentralized Clinical Trial Operations, IQVIA
Eden Stein, MBA, MSc, PMP, CCRC, Executive Director, Patient Insights and Engagement, Centricity Research
Shared Services Need to Comply, Too: Network & Community Compliance
Oncology community networks and practices have access to shared resources like administration, management, billing, information technology, accounting, and other services so to allow oncologists to focus on caring for patients. However, they are still under the same level of scrutiny when it comes to complying with regulatory criteria and audits. In this session, we will discuss how to best support community networks to help them remain compliant.
Facilitator
Susan S. Night, JD, LLSM, VP Site Engagement and Network Strategy, TD2
Panelists
Edmond Kabagambe, DVM, MS, PhD, MBA, Vice President, LGH Research Administration, Penn Medicine
Sandy Smith, RN, MSN, AOCN, SVP, Clinical Solutions & Strategic Partnering, WCG
Arla Yost, MSc, Clinical Research Operations Director, UCSF Helen Diller Family Comprehensive Cancer Center
Budgeting & Contracting Requirements for Complex Trials
More complex trials are leading to budgeting challenges for sites. What are sites missing in their oncology contracts and budgets? Come learn about contracting and budgeting tips to aid in rapid activations or fast track, master agreements for multiple sites, how to outsource to remove the burden from sites, and third-party negotiation tactics.
Facilitator
Jennifer Doraski, US Site Partnership Manager, Oncology, Sanofi
Panelists
Jessica Budzinski, MS, CCRP, Solution Engineer II, Greenphire
Geoff Schick, MBA, CHRC, Director, Strategic Site Partnerships, WCG
Alison Ivey, RN, MS, MBA, OCN, CCRP, Administrative Director, Clinical Research Office, UF Health Cancer Center